BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15654739)

  • 1. Structural properties of the promiscuous VP16 activation domain.
    Jonker HR; Wechselberger RW; Boelens R; Folkers GE; Kaptein R
    Biochemistry; 2005 Jan; 44(3):827-39. PubMed ID: 15654739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsically unstructured domain of PC4 modulates the activity of the structured core through inter- and intramolecular interactions.
    Jonker HR; Wechselberger RW; Boelens R; Kaptein R; Folkers GE
    Biochemistry; 2006 Apr; 45(15):5067-81. PubMed ID: 16605275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human general transcription factor TFIIB: conformational variability and interaction with VP16 activation domain.
    Hayashi F; Ishima R; Liu D; Tong KI; Kim S; Reinberg D; Bagby S; Ikura M
    Biochemistry; 1998 Jun; 37(22):7941-51. PubMed ID: 9609687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradual phosphorylation regulates PC4 coactivator function.
    Jonker HR; Wechselberger RW; Pinkse M; Kaptein R; Folkers GE
    FEBS J; 2006 Apr; 273(7):1430-44. PubMed ID: 16689930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
    Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
    J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR structure of the amino-terminal domain from the Tfb1 subunit of TFIIH and characterization of its phosphoinositide and VP16 binding sites.
    Di Lello P; Nguyen BD; Jones TN; Potempa K; Kobor MS; Legault P; Omichinski JG
    Biochemistry; 2005 May; 44(21):7678-86. PubMed ID: 15909982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TFIIB-facilitated recruitment of preinitiation complexes by a TAF-independent mechanism.
    Hori RT; Xu S; Hu X; Pyo S
    Nucleic Acids Res; 2004; 32(13):3856-63. PubMed ID: 15272087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the carboxyl-terminal domain of RAP74 and NMR characterization of the FCP1-binding sites of RAP74 and human TFIIB.
    Nguyen BD; Chen HT; Kobor MS; Greenblatt J; Legault P; Omichinski JG
    Biochemistry; 2003 Feb; 42(6):1460-9. PubMed ID: 12578358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of in vitro interactions implicates TATA-binding protein as a target of the VP16C transcriptional activation region.
    Nedialkov YA; Triezenberg SJ
    Arch Biochem Biophys; 2004 May; 425(1):77-86. PubMed ID: 15081896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activator-induced conformational change in general transcription factor TFIIB.
    Roberts SG; Green MR
    Nature; 1994 Oct; 371(6499):717-20. PubMed ID: 7935820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizosaccharomyces pombe positive cofactor 4 stimulates basal transcription from TATA-containing and TATA-less promoters through Mediator and transcription factor IIA.
    Contreras-Levicoy J; Urbina F; Maldonado E
    FEBS J; 2008 Jun; 275(11):2873-83. PubMed ID: 18459978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors.
    Shen F; Triezenberg SJ; Hensley P; Porter D; Knutson JR
    J Biol Chem; 1996 Mar; 271(9):4827-37. PubMed ID: 8617752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation.
    Ge H; Si Y; Roeder RG
    EMBO J; 1998 Nov; 17(22):6723-9. PubMed ID: 9822615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple hTAF(II)31-binding motifs in the intrinsically unfolded transcriptional activation domain of VP16.
    Kim DH; Lee SH; Nam KH; Chi SW; Chang I; Han KH
    BMB Rep; 2009 Jul; 42(7):411-7. PubMed ID: 19643037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR structure of the human Mediator MED25 ACID domain.
    Bontems F; Verger A; Dewitte F; Lens Z; Baert JL; Ferreira E; de Launoit Y; Sizun C; Guittet E; Villeret V; Monté D
    J Struct Biol; 2011 Apr; 174(1):245-51. PubMed ID: 20974256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing Zn2+-binding effects on the zinc-ribbon domain of human general transcription factor TFIIB.
    Ghosh M; Elsby LM; Mal TK; Gooding JM; Roberts SG; Ikura M
    Biochem J; 2004 Mar; 378(Pt 2):317-24. PubMed ID: 14641108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced alpha helix in the VP16 activation domain upon binding to a human TAF.
    Uesugi M; Nyanguile O; Lu H; Levine AJ; Verdine GL
    Science; 1997 Aug; 277(5330):1310-3. PubMed ID: 9271577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular shapes of transcription factors TFIIB and VP16 in solution: implications for recognition.
    Grossmann JG; Sharff AJ; O'Hare P; Luisi B
    Biochemistry; 2001 May; 40(21):6267-74. PubMed ID: 11371188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus tegument protein VP22 contains an internal VP16 interaction domain and a C-terminal domain that are both required for VP22 assembly into the virus particle.
    Hafezi W; Bernard E; Cook R; Elliott G
    J Virol; 2005 Oct; 79(20):13082-93. PubMed ID: 16189010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the interaction between the acidic activation domain of VP16 and the RNA polymerase II initiation factor TFIIB.
    Gupta R; Emili A; Pan G; Xiao H; Shales M; Greenblatt J; Ingles CJ
    Nucleic Acids Res; 1996 Jun; 24(12):2324-30. PubMed ID: 8710503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.